Starpharma Holdings Ltd. (OTCMKTS:SPHRY – Get Free Report)’s share price traded up 10% on Wednesday . The company traded as high as $3.30 and last traded at $3.30. 5,603 shares changed hands during trading, an increase of 2,043% from the average session volume of 262 shares. The stock had previously closed at $3.00.
Starpharma Price Performance
The company’s 50 day simple moving average is $3.08 and its 200-day simple moving average is $2.50.
About Starpharma
Starpharma is a clinical-stage biopharmaceutical company specializing in the development of dendrimer-based products across infectious disease, oncology and ophthalmology. Its proprietary dendrimer platform, DEP™ (Dendrimer Enhanced Products), enables precise molecular engineering to enhance drug delivery, targeting and safety profiles. The company’s lead product, VivaGel®, is a topical microbicide that has been approved in multiple markets for the treatment and prevention of bacterial vaginosis and is in clinical development for antiviral applications.
In addition to VivaGel, Starpharma is advancing pipeline candidates that leverage DEP technology to improve the performance of established and novel therapeutic agents.
See Also
Receive News & Ratings for Starpharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Starpharma and related companies with MarketBeat.com's FREE daily email newsletter.
